"Flavonoids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of phenyl benzopyrans named for having structures like FLAVONES.
Descriptor ID |
D005419
|
MeSH Number(s) |
D03.383.663.283.266.450 D03.633.100.150.266.450
|
Concept/Terms |
Flavonoids- Flavonoids
- 2-Phenyl-Chromenes
- 2 Phenyl Chromenes
- 2-Phenyl-Benzopyrans
- 2 Phenyl Benzopyrans
|
Below are MeSH descriptors whose meaning is more general than "Flavonoids".
Below are MeSH descriptors whose meaning is more specific than "Flavonoids".
This graph shows the total number of publications written about "Flavonoids" by people in this website by year, and whether "Flavonoids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2001 | 0 | 2 | 2 |
2002 | 2 | 4 | 6 |
2003 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2005 | 1 | 3 | 4 |
2006 | 1 | 4 | 5 |
2007 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2013 | 3 | 0 | 3 |
2016 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Flavonoids" by people in Profiles.
-
Bielory L, Tabliago NRA. Flavonoid and cannabinoid impact on the ocular surface. Curr Opin Allergy Clin Immunol. 2020 10; 20(5):482-492.
-
Fanelli Kuczmarski M, Sebastian RS, Goldman JD, Murayi T, Steinfeldt LC, Eosso JR, Moshfegh AJ, Zonderman AB, Evans MK. Dietary Flavonoid Intakes Are Associated with Race but Not Income in an Urban Population. Nutrients. 2018 Nov 13; 10(11).
-
Morales F, Giordano A. Overview of CDK9 as a target in cancer research. Cell Cycle. 2016; 15(4):519-27.
-
Jones JA, Rupert AS, Poi M, Phelps MA, Andritsos L, Baiocchi R, Benson DM, Blum KA, Christian B, Flynn J, Penza S, Porcu P, Grever MR, Byrd JC. Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non-Hodgkin's lymphoma. Am J Hematol. 2014 Jan; 89(1):19-24.
-
Andrae-Marobela K, Ghislain FW, Okatch H, Majinda RR. Polyphenols: a diverse class of multi-target anti-HIV-1 agents. Curr Drug Metab. 2013 May; 14(4):392-413.
-
Cao J, Xia X, Dai X, Xiao J, Wang Q, Andrae-Marobela K, Okatch H. Flavonoids profiles, antioxidant, acetylcholinesterase inhibition activities of extract from Dryoathyrium boryanum (Willd.) Ching. Food Chem Toxicol. 2013 May; 55:121-8.
-
Caracciolo V, Laurenti G, Romano G, Carnevale V, Cimini AM, Crozier-Fitzgerald C, Gentile Warschauer E, Russo G, Giordano A. Flavopiridol induces phosphorylation of AKT in a human glioblastoma cell line, in contrast to siRNA-mediated silencing of Cdk9: Implications for drug design and development. Cell Cycle. 2012 Mar 15; 11(6):1202-16.
-
Pera T, Gosens R, Lesterhuis AH, Sami R, van der Toorn M, Zaagsma J, Meurs H. Cigarette smoke and lipopolysaccharide induce a proliferative airway smooth muscle phenotype. Respir Res. 2010 Apr 29; 11:48.
-
Lin TS, Blum KA, Fischer DB, Mitchell SM, Ruppert AS, Porcu P, Kraut EH, Baiocchi RA, Moran ME, Johnson AJ, Schaaf LJ, Grever MR, Byrd JC. Flavopiridol, fludarabine, and rituximab in mantle cell lymphoma and indolent B-cell lymphoproliferative disorders. J Clin Oncol. 2010 Jan 20; 28(3):418-23.
-
Tacheau C, Michel L, Farge D, Mauviel A, Verrecchia F. Involvement of ERK signaling in halofuginone-driven inhibition of fibroblast ability to contract collagen lattices. Eur J Pharmacol. 2007 Nov 14; 573(1-3):65-9.